Chemoinformaics analysis of 2-Methyl-2-undecene
| Molecular Weight | 168.324 | nRot | 7 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 1 |
| Exact Molecular Weight | 168.188 | nRing | 0 |
| Solubility: LogS | -5.913 | nHRing | 0 |
| Solubility: LogP | 6.372 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 36.043 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.382 |
| Synth | 1.926 |
| Natural Product Likeliness | 1.55 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.029 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.451 |
| MDCK | 0.0000134 |
| BBB | 0.481 |
| PPB | 0.982777 |
| VDSS | 4.819 |
| FU | 0.0276899 |
| CYP1A2-inh | 0.957 |
| CYP1A2-sub | 0.234 |
| CYP2c19-inh | 0.634 |
| CYP2c19-sub | 0.482 |
| CYP2c9-inh | 0.423 |
| CYP2c9-sub | 0.91 |
| CYP2d6-inh | 0.068 |
| CYP2d6-sub | 0.078 |
| CYP3a4-inh | 0.136 |
| CYP3a4-sub | 0.108 |
| CL | 9.352 |
| T12 | 0.143 |
| hERG | 0.028 |
| Ames | 0.005 |
| ROA | 0.023 |
| SkinSen | 0.918 |
| Carcinogencity | 0.087 |
| EI | 0.969 |
| Respiratory | 0.203 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.653786 |